These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8449072)

  • 1. Effects of buspirone on anxiety levels and exercise tolerance in patients with chronic airflow obstruction and mild anxiety.
    Singh NP; Despars JA; Stansbury DW; Avalos K; Light RW
    Chest; 1993 Mar; 103(3):800-4. PubMed ID: 8449072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Buspirone effect on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease.
    Argyropoulou P; Patakas D; Koukou A; Vasiliadis P; Georgopoulos D
    Respiration; 1993; 60(4):216-20. PubMed ID: 8265878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose response study of ipratropium bromide aerosol on maximum exercise performance in stable patients with chronic obstructive pulmonary disease.
    Ikeda A; Nishimura K; Koyama H; Tsukino M; Mishima M; Izumi T
    Thorax; 1996 Jan; 51(1):48-53. PubMed ID: 8658369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emotional status does not alter exercise tolerance in patients with chronic obstructive pulmonary disease.
    Borak J; Chodosowska E; Matuszewski A; Zielinski J
    Eur Respir J; 1998 Aug; 12(2):370-3. PubMed ID: 9727787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reanalysis of the 12-minute walk in patients with chronic obstructive pulmonary disease.
    Bernstein ML; Despars JA; Singh NP; Avalos K; Stansbury DW; Light RW
    Chest; 1994 Jan; 105(1):163-7. PubMed ID: 8275726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inspiratory capacity, dynamic hyperinflation, breathlessness, and exercise performance during the 6-minute-walk test in chronic obstructive pulmonary disease.
    Marin JM; Carrizo SJ; Gascon M; Sanchez A; Gallego B; Celli BR
    Am J Respir Crit Care Med; 2001 May; 163(6):1395-9. PubMed ID: 11371407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of discriminative properties among disease-specific questionnaires for measuring health-related quality of life in patients with chronic obstructive pulmonary disease.
    Hajiro T; Nishimura K; Tsukino M; Ikeda A; Koyama H; Izumi T
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):785-90. PubMed ID: 9517591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buspirone for management of dyspnea in cancer patients receiving chemotherapy: a randomized placebo-controlled URCC CCOP study.
    Peoples AR; Bushunow PW; Garland SN; Heckler CE; Roscoe JA; Peppone LL; Dudgeon DJ; Kirshner JJ; Banerjee TK; Hopkins JO; Dakhil SR; Flannery MA; Morrow GR
    Support Care Cancer; 2016 Mar; 24(3):1339-47. PubMed ID: 26329396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of pentoxifylline on oxygenation, diffusion of carbon monoxide, and exercise tolerance in patients with COPD.
    Sasse SA; Causing LA; Stansbury DW; Light RW
    Chest; 1995 Dec; 108(6):1562-7. PubMed ID: 7497761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of lung function, maximal inspiratory pressure, dyspnoea, and quality of life with exercise capacity in patients with chronic obstructive pulmonary disease.
    Wijkstra PJ; TenVergert EM; van der Mark TW; Postma DS; Van Altena R; Kraan J; Koëter GH
    Thorax; 1994 May; 49(5):468-72. PubMed ID: 8016768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of increasing doses of beta agonists on spirometric parameters, exercise capacity, and quality of life in patients with chronic airflow limitation.
    Jaeschke R; Guyatt GH; Willan A; Cook D; Harper S; Morris J; Ramsdale H; Haddon R; Newhouse M
    Thorax; 1994 May; 49(5):479-84. PubMed ID: 8016770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT and physiologic determinants of dyspnea and exercise capacity during the six-minute walk test in mild COPD.
    Díaz AA; Morales A; Díaz JC; Ramos C; Klaassen J; Saldías F; Aravena C; Díaz R; Lisboa C; Washko GR; Díaz O
    Respir Med; 2013 Apr; 107(4):570-9. PubMed ID: 23313036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of digoxin on exercise capacity and right ventricular function during exercise in chronic airflow obstruction.
    Brown SE; Pakron FJ; Milne N; Linden GS; Stansbury DW; Fischer CE; Light RW
    Chest; 1984 Feb; 85(2):187-91. PubMed ID: 6319087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiological and symptom determinants of exercise performance in patients with chronic airway obstruction.
    Foglio K; Carone M; Pagani M; Bianchi L; Jones PW; Ambrosino N
    Respir Med; 2000 Mar; 94(3):256-63. PubMed ID: 10783937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of arterial oxygen desaturation on six minute walk distance, perceived effort, and perceived breathlessness in patients with airflow limitation.
    Mak VH; Bugler JR; Roberts CM; Spiro SG
    Thorax; 1993 Jan; 48(1):33-8. PubMed ID: 8434350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease.
    Hajiro T; Nishimura K; Tsukino M; Ikeda A; Koyama H; Izumi T
    Am J Respir Crit Care Med; 1998 Oct; 158(4):1185-9. PubMed ID: 9769280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indomethacin and perception of dyspnea in chronic airflow obstruction.
    Schiffman GL; Stansbury DW; Fischer CE; Sato RI; Light RW; Brown SE
    Am Rev Respir Dis; 1988 May; 137(5):1094-8. PubMed ID: 3195807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of the anxiolytic effects of buspirone in high- and low-anxious normal humans assessed by frontal midline theta activity.
    Mizuki Y; Suetsugi M; Ushijima I; Yamada M
    Methods Find Exp Clin Pharmacol; 1994 May; 16(4):291-300. PubMed ID: 7519702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxygen may improve dyspnea and endurance in patients with chronic obstructive pulmonary disease and only mild hypoxemia.
    Dean NC; Brown JK; Himelman RB; Doherty JJ; Gold WM; Stulbarg MS
    Am Rev Respir Dis; 1992 Oct; 146(4):941-5. PubMed ID: 1416422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the effects of prednisolone and mianserin on ventilatory, exercise and psychometric parameters in patients with chronic obstructive pulmonary disease.
    Grove A; Lipworth BJ; Ingram CG; Clark RA; Dhillon DP
    Eur J Clin Pharmacol; 1995; 48(1):13-8. PubMed ID: 7621841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.